title: Recurrence of autoimmune liver diseases after liver transplantation: clinical aspects.
abstract: Autoimmune hepatitis, primary biliary cirrhosis and primary sclerosing cholangitis are autoimmune liver diseases characterized by progressive immune-mediated inflammation leading to the destruction of the hepatocytes and the biliary epithelial cells, and eventually to cirrhosis and liver failure. The ultimate treatment of these diseases, upon the establishment of end-stage liver disease, includes liver transplantation (LT). Recurrence of autoimmune liver diseases after LT is an entity increasingly recognized in the last few decades. The mechanisms driving recurrence remain poorly understood. The accurate diagnosis of the recurrence and the proper management of the affected patients remains a clinical challenge. This review discusses clinical aspects related to the recurrence of autoimmune liver diseases after LT. The main goals of this review are to discuss the reasons explaining the variability of the incidence rates of recurrent autoimmune disease and the outcome and risk factors for recurrent disease. We discuss in detail the diagnostic criteria and the treatment options of these disorders.
authors.affiliation: 4th Department of Internal Medicine, Aristotle University Medical School, Hippokration General Hospital of Thessaloniki, Thessaloniki, Greece.
authors.forename: Evangelos
authors.initials: E
authors.lastname: Cholongitas
authors.affiliation: The Sheila Sherlock Liver Centre, University College Institute of Digestive and Liver Health, Royal Free Hospital, London, UK.
authors.forename: Andrew K
authors.initials: AK
authors.lastname: Burroughs
keywords: Autoimmune hepatitis; Autoimmune liver disease; Liver transplantation; Primary biliary cirrhosis; Primary sclerosing cholangitis; Recurrence